Jo Cheah speaks to clinical pharmacist Samuel Ford about his article on acute hyperkalaemia. Samuel discusses the presentation and diagnosis of acute hyperkalaemia, the current stepwise approach to management, highlighting what has changed and how to prevent treatment complications such as hypoglycaemia, and the importance of restarting renin–angiotensin–aldosterone system inhibitors (e.g. ACE inhibitors) once serum potassium concentration has normalised. Read the full article in Australian Prescriber.